Biocryst reports inducement grants under nasdaq listing rule 5635(c)(4)

Research triangle park, n.c., march 06, 2025 (globe newswire) -- biocryst pharmaceuticals, inc. (nasdaq: bcrx) today announced that the compensation committee of biocryst's board of directors granted seven newly-hired employees restricted stock units (rsus) covering an aggregate of 65,900 shares of biocryst common stock. the rsus were granted as of march 3, 2025, as inducements material to each employee entering into employment with biocryst. the rsus were granted in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking